Advertisement

Topics

Locus Pharmaceuticals, Inc. Company Profile

20:29 EDT 20th September 2018 | BioPortfolio

Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs. The foundation and competitiveness of Locus is based on the effective integration of our revolutionary computational technology with chemistry and biology expertise.

Location

4 Valley Square512 E. Township Line Road
Blue Bell
Pennsylvania
19422
United States of America

Contact

Phone: (215) 358-2000
Fax: (215) 358-2010
Email: locus-info@locuspharma.com


News Articles [348 Associated News Articles listed on BioPortfolio]

Locus Bio acquires phage discovery platform from EpiBiome

Locus Biosciences Inc. has acquired EpiBiome Inc.'s high-throughput bacteriophage discovery platform.

Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels

A relationship quantitative trait locus exists when the correlation between multiple traits varies by genotype for that locus. Relationship quantitative trait loci (rQTL) are often involved in gene-by...

Zebrafish research highlights role of locus coeruleus in anesthesia

(Chinese Academy of Sciences Headquarters) Recently, researchers from the Institute of Neuroscience and Zunyi Medical College, by using a larval zebrafish model, revealed that two commonly used intrav...

CRISPR-Cas3 Platform Developer Locus Biosciences Acquires EpiBiome Phage Technology

Locus Biosciences, a developer of CRISPR-Cas3-engineered precision antibacterial products, has acquired EpiBiome’s high-throughput bacteriophage phage discovery platform for an undisclosed price, in...

The ventromedial prefrontal cortex: a putative locus for trait inattention

Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis

Regulation of invariant NKT cell development and function by a 0.14 Mbp locus on chromosome 1: a possible role for Fcgr3

The relationship between parental locus of control and adolescent obesity: a longitudinal pre-birth cohort

Drugs and Medications [275 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [391 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

The Effects of Religion and Locus of Control on Perception of Mental Illness.

The study investigated the influence of religion and locus of control on perception of mental illness. Specifically, the study explored the relationship between religiosity and perception of mental il...

Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.

The advent of locus-specific protein recruitment technologies has enabled a new class of studies in chromatin biology. Epigenome editors enable biochemical modifications of chromatin at almost any spe...

Clinical Trials [279 Associated Clinical Trials listed on BioPortfolio]

Locus of Control and Spirituality in Palliative Care Patients

Primary Objectives: 1. To determine whether the degree of spirituality/religiosity as determined by the Duke University Religion Index and Functional Assessment of Chronic Illness ...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean Population

This study is to investigate whether variants in the LOC387715 locus and the HtrA serine peptidase 1 (HTRA1) gene within the 10q26 locus are associated with polypoidal choroidal vasculopat...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1333 Associated Companies listed on BioPortfolio]

Locus Pharmaceuticals, Inc.

Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs. The foundation and competitiveness ...

Locus Discovery Incorporated

Locus Discovery Inc. is a privately held chemogenomics biopharmaceutical company organized in September 1999, and is based on technology exclusively licensed from the Sarnoff Corporation (SRI Internat...

Locus Genex Oy

Monoclonal Antibodies to Human Neurotransmitter Substances.manufacturer and supplier of monoclonals antibodies.

Ansaris

Ansaris is a division of Locus Pharmaceuticals, a privately held biopharmaceutical company focused on solving today’s small molecule drug discovery challenges, has been the l...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Locus Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Locus Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Locus Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Locus Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Locus Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Locus Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record